Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening

Public Health Reports

Volumn 112, Issue 6, 1997, Pages 513-523

  Heymann, Sally Jody ^a   Brewer, Timothy F ^b,c,d   Ettling, Mary ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG SENSITIVITY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS; UNITED STATES;

BACTERIOLOGICAL TECHNIQUES; COST CONTROL; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG RESISTANCE, MICROBIAL; HEALTH EXPENDITURES; HUMANS; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 0030780236     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Expanded tuberculosis surveillance and tuberculosis morbidity - United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:361-6.
2. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40: 585-91.
3. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326: 1514-21.
4. Fischl MA, Uttamchandani RB, Daikos GL, Poblete RB, Moreno JN, Reyes RR, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992;117: 177-83.
5. Brudney K, Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Semin Respir Infect 1991;6:261-72.
6. National action plan to combat multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41(RR-11): 1-30.
7. Initial therapy for tuberculosis in the era of multidrug resistance - recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993;42:1-8.
8. Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993;31:767-70.
9. Woods GL, Witebsky FG. Current status of mycobacterial testing in clinical laboratories - results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology Survey. Arch Pathol Lab Med 1993;117:876-84.
10. Huebner RE, Good RC, Tokars JI. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol 1993;31:771-5.
11. Forbes BA, Hicks KES. Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction. J Clin Microbiol 1993; 31:1688-94.
12. Miller N, Hernandez SG, Cleary TJ. Evaluation of GenProbe amplified Mycobacterium tuberculosis direct test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol 1994;32:393-7.
13. Kirihara JM, Hillier SL, Coyle MB. Improved detection times for Mycobacterium avium and Mycobacterium tuberculosis with BACTEC radiometric system. J Clin Microbiol 1985;22:841-5.
14. Good RC. Isolation of nontuberculous mycobacteria in the United States, 1979. J Infect Dis 1980;142:779-83.
15. Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71.
16. Eisenach KD, Sifford MD, Cave MD, Bates JH, Crawford JT. Detection of Mycobacterium tuberculosis in sputum samples using polymerase chain reaction. Am Rev Respir Dis 1991;144:1160-3.
17. Cousins DV, Wilton SD, Francis BR, Gow BL. Use of polymerase chain reaction for rapid diagnosis of tuberculosis. J Clin Microbiol 1992;30:255-8.
18. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993;329:784-91.
19. Centers for Disease Control and Prevention (US). Tuberculosis program management report case register for calendar 1992. Atlanta (GA): CDC; 1993.
20. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527-32.
21. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62 dose, 6 month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990;112:407-15.
22. Department of Commerce (US). Statistical abstract of the United States. 113th ed. Washington: Bureau of the Census; 1993.
23. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994;271:1083-7.
24. Thompson NJ. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five year of follow-up of the IUAT trial. Bull World Health Organ 1982;60:555-64.
25. National Tuberculosis Institute, Bangalore (India). Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 1974;51:473-88.
26. Massachusetts Department of Public Health. Listing of state payments for treatment of clinic-based TB cases. Boston: The Department; 1993.
27. Snider DE, Caras GJ, Koplan JP. Preventive therapy with isoniazid. JAMA 1986;255:1579-83.
28. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. JAMA 1993;270:65-8.
29. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City [published erratum appears in N Engl J Med 1993;329:148]. N Engl J Med 1993;328: 521-6.
30. Fischl MA, Daikos GL, Uttamchandani RB, Poblete RB, Moreno JN, Reyes RR, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992;117:184-90.
31. Salomon N, Perlman DC, Friedmann P, Buchstein S, Dreiswirth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995;21: 1245-52.
32. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Eng J Med 1991;324:289-94.
33. Centers for Disease Control and Prevention (US). Reported tuberculosis in the United States, 1993. Atlanta: CDC; 1994. p. 1-42.
34. Clarridge JE, Shawar RM, Shinnick TM, Plikaytis BB. Large-scale use of PCR for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol 1993;31:2049-56.
35. Elliott AM, Namaambo K, Allen BW, Luo N, Hayes RJ, Pobee JO, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis 1993;74:191-4.
36. Kiehn TE, Cammarata R. Laboratory diagnosis of mycobacterial infection in patients with AIDS. J Clin Microbiol 1986;24:708-11.
37. Anargyros P, Astill DSJ, Lim ISL. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J Clin Microbiol 1990;28:1288-91.
38. Park CH, Hixon DL, Ferguson CB, Hall SL, Risheim CC, Cook BC. Rapid recovery of mycobacteria from clinical specimens using a radiometric technique. Am J Clin Path 1984;81:341-5.
39. Damato JJ, Collins MT, Rothlauf MV, McClatchy JK. Detection of mycobacteria by radiometric and standard plate procedures. J Clin Microbiol 1983;17:1066-73.
40. Stager CE, Libonati JP, Siddiqi SH, Davis JR, Hooper NM, Baker JF, et al. Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification. J Clin Microbiol 1991;29:154-7.
41. MacGregor RR, Clark LW, Bass F. The significance of isolating low numbers of Mycobacterium tuberculosis in culture of sputum specimens. Chest 1975;68:518-23.
42. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City an analysis by DNA fingerprinting and conventional epidemiologic methods. N Eng J Med 1994;330:1710-6.
43. D'Amato RF, Isenberg HD, Hochstein L, Mastellone AJ, Alperstein P. Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria. J Clin Microbiol 1991;29:2906-8.
44. Chin DP, Yajko DM, Hadley WK, et al. Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med 1995;151:1872-7.
45. Abe C, Hirano K, Wada M, Kazumi Y, Takahashi M, Fukasawa Y, et al. Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol 1993;31:3270-4.
46. Bradley SP, Reed SL, Catanzaro A. Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153:1606-10.
47. Yuen KY, Chan KS, Chan CM, Ho BSW, Dai LK, Chau PY, et al. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Pathol 1993;45: 318-22.
48. Laszlo A, Handel V. Radiometric diagnosis of mycobacteria. Eur J Clin Microbiol 1986;5:152-5.
49. Lumb R, Lanser JA, Lim IS. Rapid identification of mycobacteria by the Gen-Probe Accuprobe system. Pathology 1993;25:313-5.
50. Peterson EM, Lu R, Floyd C, Nakasone A, Friedly G, de la Maza LM. Direct identification of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intra cellulare from amplified primary cultures in BACTEC media using DNA probes. J Clin Microbiol 1989;27:1543-7.
51. Thibert L, Lapierre S. Routine application of high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol 1993;31:1759-63.
52. Guthertz LS, Lim SD, Jang Y, Duffey PS. Curvilinear-gradient high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol 1993;31:1876-81.
53. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, McClathcy JK, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983;18:689-96.
54. Salfinger M, Demchuk BS, Kafader FM. Comparison between the MB check broth, radiometric, and conventional methods for recovery of mycobacteria from respiratory specimens. J Microbiol Methods 1990;12:97-100.
55. Sewell DL. Comparison of the Septi-Chek AFB and BACTEC Systems and conventional culture for recovery of mycobacteria. J Clin Microbiol 1993;31:2689-91.
56. Laszlo A, Siddiqi SH. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone. J Clin Microbiol 1984;19:694-8.
57. Soo Hoo GW, Palmer DL, Sopher RL. Reducing tuberculosis detection costs. Chest 1984;86:860-2.
58. Department of Commerce (US). Statistical abstract of the United States. 115th ed. Washington: Bureau of the Census; 1995.